Growth hormone, IGF-I, and insulin are known to influence these pathways, which have provided the basis for their use as PEDs (see figure 1)
The drugs are increasingly being used as an appetite suppressant by people looking to lose weight
Graphical tools for network meta-analysis in STATA
They're there to answer questions, adjust your position, or simply chat if you'd like company
Recent studies have corroborated these results (Reference Al-Harbi, Imam and Nadeem22Reference Bashandy, Ebaid and Moussa26,Reference Naseem, Hassan and Alhazza28,Reference Salman and Naseem29,Reference Alam, Iqbal and Naseem31,Reference Jiang, Chen and Liu33Reference Tang, Wen and Guo36)
For the compound profile, see GHRP-2 in the Clinical Peptide library